FindTrial
Sign In

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) versus Conventional Treatment in Acute Myocarditis

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-513803-15-00
Enrollment
150
Registered
2024-09-16
Start date
2025-01-30
Completion date
Unknown
Last updated
2025-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myocarditis

Brief summary

Change in late gadolinium enhancement (measured in % relative to indexed myocardial mass) compared to baseline (cardiac magnetic resonance at admission) in each treatment group at 6 months after diagnosis.

Interventions

DRUGIBUPROFEN

Sponsors

Centro Nacional De Investigaciones Cardiovasculares Carlos III, Fundacion Para La Investigacion Biomedica Del Hospital Universitario Puerta De Hierro Majadahonda
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Change in late gadolinium enhancement (measured in % relative to indexed myocardial mass) compared to baseline (cardiac magnetic resonance at admission) in each treatment group at 6 months after diagnosis.—

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026